Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested.
Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested today, by introducing the first “Organism-on-Chip” technology.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 21, 2022 | Grant | €2.50M | 1 | European Innovation Council | — | Detail |
Dec 20, 2019 | Seed | Fr1.80M | 2 | Verve Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European Innovation Council | Yes | Grant |
Verve Ventures | Yes | Seed |
NEST pension fund | — | Seed |